Malignant Melanoma in a Retrospective Cohort of Immunocompromised Patients: A Statistical and Pathologic Analysis

SIMPLE SUMMARY: Despite recent advances in immunotherapy, melanoma remains the deadliest cutaneous malignancy. Immunocompromised patients are at heightened risk of developing melanoma and experience greater levels of morbidity and mortality compared to their non-immunocompromised peers with the dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Killeen, Trevor F., Shanley, Ryan, Ramesh, Vidhyalakshmi, Giubellino, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377403/
https://www.ncbi.nlm.nih.gov/pubmed/37509262
http://dx.doi.org/10.3390/cancers15143600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377403/
https://www.ncbi.nlm.nih.gov/pubmed/37509262
http://dx.doi.org/10.3390/cancers15143600

Ejemplares similares